Answers are grounded in this paper and cite their sources.
Background: Hospital medication interventions are often judged by the prescriptions reviewed, discrepancies corrected, or recommendations accepted. These measures describe necessary work, but they do not establish whether patients receive safer, more effective, or less burdensome treatment. Aim: This critical narrative review aims to explore the broader role and potential applications of artificial intelligence (AI) in hospital medication prescribing and stewardship, rather than to evaluate one specific software application. This critical review examines the organizational and technological conditions that connect prescribing decisions to patient benefit in adults with multimorbidity or polypharmacy, from admission through early follow-up after discharge. Methods: Targeted searches of journal literature, citation tracing, and bibliographic verification informed a narrative appraisal of medication reconciliation, pharmacist-led optimization, deprescribing, clinical decision support, and transitional care. Results: The evidence distinguishes improvements in prescribing processes from effects on medication-related harm and health care utilization. Differences between studies may reflect patient selection, intervention delivery, baseline services, follow-up, and outcome measurement, as well as limited intervention effectiveness. We propose a hospital medication stewardship program in which verified medication information supports prioritized review, documented decisions, assigned responsibility, confirmed handover, and reassessment. Standard software, rule-based support, predictive models, and language models serve different tasks; each requires evidence proportionate to its intended clinical role. A three-condition evaluation compares usual care with a structured digital program and the same program with added artificial intelligence (AI), allowing the effect of the structured stewardship package and the incremental value of AI to be assessed separately. Clinical outcomes should be considered alongside patient experience, workload, costs, equity, and unintended effects. Conclusions: The framework is a proposal for prospective evaluation. Its central proposition is that medication stewardship should make the path from a recommendation to an implemented and reviewed decision observable, while testing whether that additional structure improves outcomes that matter to patients. AI-supported stewardship should be adopted only after prospective evidence of patient benefit, feasible delivery, acceptable burden, and equitable access.
No takes yet. Share an insight, caveat, or question.
Pratama et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: